Carregant...

Comparative Bacteriological Efficacy of Pharmacokinetically Enhanced Amoxicillin-Clavulanate against Streptococcus pneumoniae with Elevated Amoxicillin MICs and Haemophilus influenzae

A new pharmacokinetically enhanced formulation of amoxicillin-clavulanate (2,000 mg of amoxicillin/125 mg of clavulanate twice a day; ratio 16:1) has been designed, with sustained-release technology, to allow coverage of bacterial strains with amoxicillin-clavulanic acid MICs of at least 4/2 μg/ml....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Berry, Valerie, Hoover, Jennifer, Singley, Christine, Woodnutt, Gary
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2005
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC549224/
https://ncbi.nlm.nih.gov/pubmed/15728883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.3.908-915.2005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!